Antibiotic Resistance Profiles and Multidrug Resistance Patterns of Streptococcus Pneumoniae in Pediatrics
Cai-yun Wang,Ying-Hu Chen,Chao Fang,Ming-ming Zhou,Hong-mei Xu,Chun-mei Jing,Hui-ling Deng,Hui-jun Cai,Kai Jia,Shu-zhen Han,Hui Yu,Ai-min Wang,Dan-dan Yin,Chuan-qing Wang,Wei Wang,Wei-chun Huang,Ji-kui Deng,Rui-zhen Zhao,Yi-ping Chen,Ji-Hong Yang,Chun Wang,Yan-ran Che,Xiu-zhen Nie,Shi-fu Wang,Jian-hua Hao,Cong-hui Zhang
DOI: https://doi.org/10.1097/md.0000000000015942
IF: 1.6
2019-01-01
Medicine
Abstract:Abstract Emergent resistance to antibiotics among Streptococcus pneumoniae isolates is a severe problem worldwide. Antibiotic resistance profiles for S pneumoniae isolates identified from pediatric patients in mainland China remains to be established. The clinical features, antimicrobial resistance, and multidrug resistance patterns of S pneumoniae were retrospectively analyzed at 10 children's hospitals in mainland China in 2016. Among the collected 6132 S pneumoniae isolates, pneumococcal diseases mainly occurred in children younger than 5 years old (85.1%). The resistance rate of S pneumoniae to clindamycin, erythromycin, tetracycline, and trimethoprim/sulfamethoxazole was 95.8%, 95.2%, 93.6%, and 66.7%, respectively. The resistance rates of S pneumoniae to penicillin were 86.9% and 1.4% in non-meningitis and meningitis isolates, while the proportions of ceftriaxone resistance were 8.2% and 18.1%, respectively. Pneumococcal conjugate vaccine was administered to only 4.1% of patients. Penicillin and ceftriaxone resistance, underling diseases, antibiotic resistant risk factors, and poor prognosis appeared more frequently in invasive pneumococcal diseases. The incidence of multidrug resistance (MDR) was 46.1% in patients with invasive pneumococcal disease which was more than in patients with non-invasive pneumococcal disease (18.3%). Patients with invasive pneumococcal disease usually have several MDR coexistence. S pneumoniae isolates showed high resistance to common antibiotics in mainland China. Penicillin and ceftriaxone resistance rate of invasive streptococcal pneumonia patients were significantly higher than that of non-invasive S pneumoniae patients. Alarmingly, 46.1% of invasive clinical isolates were multidrug resistant, so it is important to continued monitor the resistance of S pneumoniae when protein conjugate vaccine (PCV13) is coming in mainland China.